Innovation & Tech
Novo Nordisk Stock Jumps After FDA Clears Wegovy Pill
Novo Nordisk (NVO) shares jumped after FDA approval of an oral Wegovy pill, the first GLP-1 obesity treatment in tablet form. The decision reshapes competition in weight-loss drugs and triggered a sharp market reaction to regulatory news.